Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma

BACKGROUND: In this retrospective study, we investigated the efficacy and safety of radioimmunotherapy with (90)Yttrium- ibritumomab tiuxetan ((90)Y-RIT) in 9 patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting after having achieved complete (CR) or partial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisani, Francesco, Sciuto, Rosa, Dessanti, Maria Laura, Giannarelli, Diana, Kayal, Ramy, Rea, Sandra, Marchesi, Francesco, Marino, Mirella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482187/
https://www.ncbi.nlm.nih.gov/pubmed/26120498
http://dx.doi.org/10.1186/s40164-015-0012-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482187/
https://www.ncbi.nlm.nih.gov/pubmed/26120498
http://dx.doi.org/10.1186/s40164-015-0012-3

Ejemplares similares